Fairfield Financial Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.1M | Sell |
14,196
-353
| -2% | -$275K | 3.88% | 8 |
|
|
2025
Q1 | $12M | Sell |
14,549
-119
| -0.8% | -$98.3K | 4.53% | 8 |
|
|
2024
Q4 | $11.3M | Buy |
14,668
+29
| +0.2% | +$22.4K | 3.99% | 10 |
|
|
2024
Q3 | $13M | Buy |
14,639
+429
| +3% | +$380K | 4.41% | 7 |
|
|
2024
Q2 | $12.9M | Buy |
+14,210
| New | +$12.9M | 3.79% | 8 |
|
|
2023
Q4 | $8.27M | Buy |
14,184
+592
| +4% | +$345K | 3.15% | 9 |
|
|
2023
Q3 | $7.3M | Buy |
13,592
+721
| +6% | +$387K | 3.07% | 9 |
|
|
2023
Q2 | $6.04M | Buy |
12,871
+1,310
| +11% | +$614K | 2.41% | 14 |
|
|
2023
Q1 | $3.94M | Buy |
11,561
+1,322
| +13% | +$450K | 1.71% | 17 |
|
|
2022
Q4 | $3.75M | Buy |
10,239
+224
| +2% | +$82K | 1.72% | 20 |
|
|
2022
Q3 | $3.24M | Buy |
10,015
+846
| +9% | +$274K | 1.54% | 20 |
|
|
2022
Q2 | $2.97M | Buy |
9,169
+119
| +1% | +$38.6K | 1.37% | 21 |
|
|
2022
Q1 | $2.59M | Buy |
+9,050
| New | +$2.59M | 0.94% | 26 |
|